By Kelly A. Briganti, Editorial Director, G2 Intelligence
The increased focus on individual responsibility, highlighted by last year's release of the Yates Memo, is borne out by a recent Department of Justice settlement with the former owner of a Virginia-based laboratory. Dr. David G. Bostwick, founder, owner and chief executive officer of Bostwick Laboratories between 1999 and 2011 agreed to…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
Just a few months ago, it was all systems go for Stage 3 of Meaningful Use—the Centers for Medicare and Medicaid Services (CMS) program that awards incentives for using certified electronic health records to improve patient care…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
Foundation Medicine will be collaborating with New Jersey's largest insurer and a firm that conducts comparative analysis of oncology patients to conduct comprehensive genomic profiling of patients with non-small cell…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Personalized medicine is driving the need for isolation of rarer target cell populations, including for the enrichment of circulating tumor cells (CTCs), hematopoietic stem cells, and circulating fetal cells from blood. Current molecular analysis, while increasing biological understanding of cancer and other diseases at the DNA level…
Read more...
|
